Loading provider…
Loading provider…
Rheumatology Physician in Jacksonville, FL
NPI: 1447240239Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Andy's Phone NumberMobile
Get MD Andy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
CA State Medical License
1998
FL State Medical License
1999 - 2026
GA State Medical License
2014 - 2026
KY State Medical License
2014 - 2025
MN State Medical License
1995 - 1998

American Board of Internal Medicine
Rheumatology
St Vincent Hospital
Residency • Internal Medicine
1992 - 1995
Pontifical Bolivarian University
Medical School
Until 1990
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Rheumatology
1995 - 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 173 | 197 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 76 | 76 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 58 | 58 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 37 | 37 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 25 | 25 |
2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Authors: Steven Carsons, William Docken, Mehrdad Maz
Publication Date: 2015-02-20
Authors: Florentina Berianu, Neha Narula, Neha Narula
Journal: Int J Rheum Dis
Publication Date: 2021-04-22
Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage.
Authors: Ronald Butendieck
Publication Date: 2014-07-03
Lead Sponsor: Scleroderma Research Foundation, Inc.
Collaborators: Boehringer Ingelheim, Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: Amlitelimab, DRUG: BI 1015550 (Nerandomilast)
Lead Sponsor: Mayo Clinic
Intervention / Treatment: BIOLOGICAL: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)